Literature DB >> 2820320

Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.

A J Smith, V Kyle, T E Cawston, B L Hazleman.   

Abstract

Serum samples were obtained from patients with polymyalgia rheumatica (PMR: n = 10) or giant cell arteritis (GCA; n = 7), or both. Samples were taken either before treatment or within one week of starting prednisolone. Immune complexes (IC) were concentrated by polyethylene glycol (PEG) precipitation then purified with either IgG anti-C1q-Sepharose or IgG anti-C3c-Sepharose. Complex components were separated by sodium dodecyl sulphate (SDS) gradient polyacrylamide gel electrophoresis then transferred to nitrocellulose by Western blotting. Identification of proteins was carried out using specific antisera. All the IC contained IgM (mu chain), some contained IgA (alpha chain), and IgG (gamma chain). C1r, C1s, C1q, C3, C4, and C reactive protein (CRP), where tested, were found in most but not all IC. The occurrence of properdin, factor B, alpha 2 macroglobulin (alpha 2M), factor H (beta 1H), C1 esterase inhibitor, and C4 binding protein was also investigated. Immune complexes in PMR and GCA differed from those previously characterized in rheumatoid arthritis (RA)1 purified by anti-C1q-Sepharose which contained immunoglobulins and C1q only. No properdin or factor B were detected in RA IC purified with either anti-C1q-Sepharose or anti-C3c-Sepharose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820320      PMCID: PMC1002166          DOI: 10.1136/ard.46.6.468

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Immunoglobulins in temporal arteries. An immunofluorescent study.

Authors:  G C Liang; P A Simkin; M Mannik
Journal:  Ann Intern Med       Date:  1974-07       Impact factor: 25.391

Review 2.  Preparation and properties of human C1 inhibitor.

Authors:  R B Sim; A Reboul
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

4.  Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica.

Authors:  C C Papaioannou; R C Gupta; G G Hunder; F C McDuffie
Journal:  Arthritis Rheum       Date:  1980-09

5.  Immunological and histological studies of temporal arteries from patients with temporal arteritis and/or polymyalgia rheumatica.

Authors:  E Waaler; O Tönder; E J Milde
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-01

6.  Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).

Authors:  G D Harkiss; D L Brown
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

7.  Immunological and histological study of temporal arteries.

Authors:  J R Park; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

8.  Serum levels of immunoglobulin and complement in giant-cell arteritis.

Authors:  B E Malmvall; B A Bengtsson; B Kaijser; L A Nilsson; K Alestig
Journal:  JAMA       Date:  1976-10-18       Impact factor: 56.272

9.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

10.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  5 in total

1.  Occurrence of C-reactive protein in cryoglobulins.

Authors:  S M Weiner; V Prasauskas; D Lebrecht; S Weber; H H Peter; P Vaith
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  [Facial edema as an earlier presenting sign of giant cell arteritis. Possible relationship with angioedema].

Authors:  G Bahat; S Akin; F Tufan; A Gelincik; N Erten; M A Karan
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

3.  Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments.

Authors:  A Bhatia; S Blades; G Cambridge; J C Edwards
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

4.  A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.

Authors:  Diana Pauly; Benedikt M Nagel; Jörg Reinders; Tobias Killian; Matthias Wulf; Susanne Ackermann; Boris Ehrenstein; Peter F Zipfel; Christine Skerka; Bernhard H F Weber
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

5.  Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases.

Authors:  Nicole Schäfer; Antje Grosche; Joerg Reinders; Stefanie M Hauck; Richard B Pouw; Taco W Kuijpers; Diana Wouters; Boris Ehrenstein; Volker Enzmann; Peter F Zipfel; Christine Skerka; Diana Pauly
Journal:  Front Immunol       Date:  2016-11-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.